How does etoposide exert its therapeutic effect?

How does etoposide exert its therapeutic effect?

• A. By inhibiting topoisomerase I
• B. By intercalating with DNA
• C. By inhibiting topoisomerase II
• D. By promoting apoptosis

Answer: (C)

Etoposide exerts its therapeutic effect primarily through the inhibition of topoisomerase II. Topoisomerase II is an essential enzyme that is responsible for managing DNA tangling and unwinding during DNA replication and transcription. By inhibiting this enzyme, etoposide interferes with the normal processing of DNA, leading to the accumulation of DNA breaks and ultimately triggering cell death, particularly in rapidly dividing cancer cells. This mechanism is particularly effective in treating various types of cancers, as the drug selectively targets the DNA repair processes in these malignant cells, making it a valuable agent in chemotherapy regimens. Other mechanisms mentioned, such as intercalating with DNA or promoting apoptosis, while relevant in cancer therapy, are not the primary action of etoposide. The focus on topoisomerase II inhibition highlights the drug's specific action in disrupting the cell cycle and promoting cytotoxicity in tumor cells.

Etoposide exerts its therapeutic effect primarily through the inhibition of topoisomerase II. Topoisomerase II is an essential enzyme that is responsible for managing DNA tangling and unwinding during DNA replication and transcription. By inhibiting this enzyme, etoposide interferes with the normal processing of DNA, leading to the accumulation of DNA breaks and ultimately triggering cell death, particularly in rapidly dividing cancer cells. This mechanism is particularly effective in treating various types of cancers, as the drug selectively targets the DNA repair processes in these malignant cells, making it a valuable agent in chemotherapy regimens.

Other mechanisms mentioned, such as intercalating with DNA or promoting apoptosis, while relevant in cancer therapy, are not the primary action of etoposide. The focus on topoisomerase II inhibition highlights the drug's specific action in disrupting the cell cycle and promoting cytotoxicity in tumor cells.